Why the study?
Does Nox2 deficiency prevent doxorubicin-induced cardiac contractile dysfunction and remodeling in mice?
Does Nox2 deficiency prevent doxorubicin-induced cardiac contractile dysfunction and remodeling in mice?
Nox2 NADPH oxidase contributes significantly to doxorubicin-induced cardiac contractile dysfunction and remodeling, highlighting a potential mechanistic target for cardioprotection.
No takes yet. Share an insight, caveat, or question.
Nox2 deficiency attenuates doxorubicin cardiotoxicity in mice; hypothesis-generating and requires clinical validation before practice change.
Zhao et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: